FDA-approved ALK IHC CDx superior to another IHC assay for patient selection
The U.S. Food and Drug Administration (FDA) approved VENTANA anti-ALK(D5F3)CDx performed more accurately than another commonly used immunohistochemistry (IHC) assay, based on the use of the 5A4 clone, for the selection of ...
Feb 22, 2016
0
1